We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$717M
AUM Growth
+$71.5M
Cap. Flow
+$33.3M
Cap. Flow %
4.65%
Top 10 Hldgs %
20.91%
Holding
1,827
New
392
Increased
392
Reduced
382
Closed
598

Sector Composition

Rank Sector Weight
1 Industrials 13.36%
2 Technology 10.64%
3 Real Estate 8.24%
4 Consumer Discretionary 8.2%
5 Energy 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAB icon
551
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$192K 0.03%
+6,360
New +$190K
DECK icon
552
PUT
Deckers Outdoor
DECK
$13.3B
$192K 0.03%
+19,200
New +$166K
EBS icon
553
Emergent Biosolutions
EBS
$248M
$192K 0.03%
+5,274
New +$186K
NVRI icon
554
Enviri
NVRI
$620M
$191K 0.03%
35,100
+13,400
+62% +$77.4K
PFXF icon
555
VanEck Preferred Securities ex Financials ETF
PFXF
$2.47B
$190K 0.03%
+9,435
New +$183K
FRC
556
DELISTED
First Republic Bank
FRC
$190K 0.03%
+2,850
New +$183K
FRED
557
DELISTED
Fred's Inc
FRED
$190K 0.03%
12,731
+12,091
+1,889% +$178K
MGPI icon
558
MGP Ingredients
MGPI
$375M
$189K 0.03%
7,800
+1,300
+20% +$29.9K
MMSI icon
559
Merit Medical Systems
MMSI
$5.32B
$189K 0.03%
10,200
-800
-7% -$13.9K
PFF icon
560
iShares Preferred and Income Securities ETF
PFF
$13.3B
$189K 0.03%
+4,830
New +$185K
RARE icon
561
Ultragenyx Pharmaceutical
RARE
$2.55B
$189K 0.03%
+2,993
New +$196K
FSTR icon
562
Foster
FSTR
$432M
$187K 0.03%
10,300
+1,800
+21% +$24K
EPIQ
563
DELISTED
EPIQ SYSTEMS INC
EPIQ
$185K 0.03%
12,336
+1,354
+12% +$17.4K
INGN icon
564
Inogen
INGN
$164M
$184K 0.03%
4,100
+100
+3% +$3.56K
OFIX icon
565
Orthofix Medical
OFIX
$419M
$183K 0.03%
4,400
-800
-15% -$31.4K
WIRE
566
DELISTED
Encore Wire Corp
WIRE
$183K 0.03%
4,700
-200
-4% -$7.24K
DPLO
567
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$183K 0.03%
6,664
+857
+15% +$25.2K
BIB icon
568
ProShares Ultra NASDAQ Biotechnology
BIB
$86.2M
$182K 0.03%
4,462
-3,757
-46% -$166K
JOUT icon
569
Johnson Outdoors
JOUT
$505M
$182K 0.03%
8,206
+2,143
+35% +$46.6K
JMG
570
DELISTED
JOURNAL MEDIA GROUP INC COM
JMG
$182K 0.03%
+15,200
New +$182K
NKTR icon
571
Nektar Therapeutics
NKTR
$2.58B
$181K 0.03%
878
-2,411
-73% -$463K
GNCMA
572
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$181K 0.03%
9,900
APOL
573
DELISTED
Apollo Education Group Inc Class A
APOL
$181K 0.03%
+22,000
New +$175K
CRAY
574
DELISTED
Cray, Inc.
CRAY
$180K 0.03%
+4,300
New +$164K
CSS
575
DELISTED
CSS Industries, Inc.
CSS
$179K 0.03%
6,400
+8
+0.1% +$215

Similar funds

Prelude Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Prelude Capital Management held 1,827 positions worth $717M, up 11% from $645M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Prelude Capital Management deployed $33.3M of net new capital in Q1 2016, opening 392 new positions and adding to 392 existing holdings. Its largest new stake was TALMER BANCORP INC (MI): 350,384 shares worth $6.34M.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 10% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $3.01M trimmed.

  • Prelude Capital Management's largest Q1 2016 buy was TALMER BANCORP INC (MI): 350,384 shares worth $6.34M.
  • Prelude Capital Management added most to SANDISK CORP in Q1 2016, an estimated $7.59M increase.
  • Prelude Capital Management's biggest Q1 2016 reduction was Meta Platforms (Facebook), cutting an estimated $3.01M.
  • Prelude Capital Management fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $12.1M.
  • Prelude Capital Management's ten largest holdings make up 21% of its $717M portfolio in Q1 2016.
  • Prelude Capital Management opened 392 new positions and closed 598 in Q1 2016.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $717M.

Based on Prelude Capital Management's 13F filing for Q1 2016, filed 16 May 2016.